Career Search
Explore opportunities with Novartis and Sandoz below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search.
Notice to applicants for US job openings. Learn More
Showing 1763 results
- Sort by Sort ascending
- Job Title Sort ascending
- Business
- Location
- Site
- Date Posted
Job Title Sort ascending | Business | Location | Site | Date Posted |
---|---|---|---|---|
ASCEND Director Regular, Full time | Pharmaceuticals | Ireland +Alternative Locations | Dublin (Novartis Global Service Center (NGSC)) | Jun 14, 2024 |
Head Clinical Development Pediatric CoE Regular, Full time | Pharmaceuticals | Switzerland +Alternative Locations | Basel (City) | Jun 14, 2024 |
Director Biostatistics Medical Affairs, Real World Data Expert Regular, Full time | Pharmaceuticals | United Kingdom | London (The Westworks) | Jun 14, 2024 |
Global Regulatory Submission Manager Regular, Full time | Pharmaceuticals | United Kingdom | London (The Westworks) | Jun 14, 2024 |
Director - Platform Management & Operations(Implementation- Salesforce Or Veeva) Regular, Full time | CTS | India | Hyderabad (Office) | Jun 14, 2024 |
Chef de Produit Cardio Regular, Full time | Pharmaceuticals | France | Paris Headquarter (Novartis Pharma S.A.S.) | Jun 14, 2024 |
Global Program Regulatory Manager - LCM Regular, Full time | Pharmaceuticals | United Kingdom | London (The Westworks) | Jun 14, 2024 |
Senior Global Program Regulatory Manager Regular, Full time | Pharmaceuticals | United Kingdom | London (The Westworks) | Jun 14, 2024 |
International Disease Area Head, Immunology (Dermatology) Regular, Full time | Pharmaceuticals | Switzerland | Basel (City) | Jun 14, 2024 |
Associate Director, Global Regulatory Submission Management Regular, Full time | Pharmaceuticals | United Kingdom | London (The Westworks) | Jun 14, 2024 |
Pagination
- ‹ Previous page
- 1
- …
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- …
- 177
- › Next page
To report an adverse event or any drug related issues concerning Novartis medicinal products; please contact Novartis Patient Safety: Tel: +202 22861000 - Press 3 for reporting an adverse event.
E-mail: [email protected]
للإبلاغ عن أثر جانبى أو أي مشكلة دوائية متعلقة بمنتجات نوفارتس الطبية او الاجهزة ؛ يرجى الاتصال بقسم اليقظة الدوائية في شركة نوفارتس
+202 22861000 : الهاتف
ثم اضغط 3 للإبلاغ عن أثر جانبي +
[email protected] البريد الإلكترونى